Total Funding
87
56
Total FundingVenture - Series Unknown raised
Growth Score 87 in past quarter
-5 pts
Heat Score 56 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
85867
Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
- PABLO V. ESCRIBA: President & Founder
- José Javier Muruzábal Gorri: Consultant for Development and Production
About the Company
LAMINAR PHARMA is a pioneering biopharmaceutical company that focuses on the discovery, rational design and initial clinical development of a new generation of medicines associated with a novel therapeutic approach: Membrane Lipid Therapy (MLT).